Skip to main content
Clinical Trials/CTRI/2021/04/032916
CTRI/2021/04/032916Completed未知

A prospective randomised double-blinded study on comparision of propofol and ketofol(combination of ketamine and propofol) for modified electroconvulsive therapy.

JLN medical college ajmer0 sites60 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
60

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1. Age 18 to 60 years of either sex undergoing modified ECT.
  • 2. ASA I and II grades.
  • 3. Modified ECT under general anaesthesia.
  • 4. Informed written consent.

Exclusion Criteria

  • 1. History of any serious physical disease, such as cardiovascular disease, cerebrovascular disorder, intracranial hypertension, respiratory tract disease, and severe fracture.
  • 2. Hypertension, glaucoma, arterial aneurysm, or cerebrovascular malformation.
  • 3. Presence of a foreign body, such as a pacemaker, intracranial electrode, and clips.
  • 4. History of seizures and those using anticonvulsant drugs.
  • 5. History of substance abuse or dependence, including alcohol abuse.
  • 6. ASA III,IV,V status.
  • 7. Hypersensitivity to any study drug.
  • 8. Pregnancy.

Investigators

Sponsor
JLN medical college ajmer

Similar Trials